Increase in new innovative drugs, launch of biologics products, and expansion of pharmaceutical and biotechnology industries are projected to drive the.
ALAMEDA, Calif. (BUSINESS WIRE) AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for the quarter and six months ended June 30, 2023.Balance Sheet InformationCash, cash equivalents, an.
AgeX Therapeutics, Inc. , a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for the quarter and six months ended June 30,. -Today at 04:06 pm- MarketScreener